Drug Shortage Report for RIVA-ATOMOXETINE
| Report ID | 259109 |
| Drug Identification Number | 02405997 |
| Brand name | RIVA-ATOMOXETINE |
| Common or Proper name | Riva-Atomoxetine 40mg |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ATOMOXETINE |
| Strength(s) | 40MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-06-02 |
| Actual start date | 2025-06-02 |
| Estimated end date | 2025-08-25 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-06-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-06-03 | English | Compare |
| v2 | 2025-06-02 | French | Compare |
| v1 | 2025-06-02 | English | Compare |
Showing 1 to 3 of 3